Topic: genetic medicine

Aerska's $39M Boost Targets Brain-Delivery for RNA Medicines

Aerska, a Dublin biotech firm, has secured $39 million to develop a delivery system that can transport advanced genetic medicines across the protective blood-brain barrier to treat neurodegenerative diseases. The company's technology aims to use RNA interference to target and reduce the productio...